Clinical Study of Ascending-descending Acupuncture Method Regulation of the Spleen and Stomach for Treatment of Spleen Deficiency-type Diarrhea in Irritable Bowel Syndrome
10.13460/j.issn.1005-0957.2015.01.0025
- VernacularTitle:针刺调理脾胃升降法治疗脾虚型肠易激综合征的临床研究
- Author:
Yongchun LI
- Publication Type:Journal Article
- Keywords:
Acupuncture therapy;
Irritable bowel syndrome;
Diarrhea;
Serum vasoactive intestinal peptide;
5-hydroxytryptamine;
Spleen-qi ascending stomach-qi descending
- From:
Shanghai Journal of Acupuncture and Moxibustion
2015;(1):25-27
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the efficacy of ascending-descending acupuncture method regulation of the spleen and stomach in treating spleen deficiency-type diarrhea in irritable bowel syndrome and its effect on serum vasoactive intestinal peptide (VIP) and 5-hydroxytryptamine (5-HT) levels. Methods Sixty irritable bowel syndrome patients with spleen deficiency-type diarrhea were randomly allocated to treatment and control groups, 30 cases each. The treatment group received ascending-descending acupuncture method regulation of the spleen and stomach and the control group, oral administration of pinaverium bromide. The symptom of diarrhea was scored and the vasoactive intestinal peptide and 5-hydroxytryptamine contents of serum were measured in the two groups before and after four weeks of treatment. Results There were statistically significant post-treatment differences in the diarrhea symptom score and serum vasoactive intestinal peptide and 5-hydroxytryptamine contents between the treatment and control groups (P＜0.05). There were statistically significant pre-/post-treatment differences in the diarrhea symptom score and serum vasoactive intestinal peptide and 5-hydroxytryptamine contents in the two groups (P＜0.05). Conclusion Ascending-descending acupuncture method regulation of the spleen and stomach is an effective way to treat spleen deficiency-type diarrhea in irritable bowel syndrome. It can effectively regulate the vasoactive intestinal peptide and 5-hydroxytryptamine contents of serum in the patients.
